A naturalistic outcome study of risperidone treatment among hospital patients
- 1 October 1996
- journal article
- research article
- Published by American Psychiatric Association Publishing in Psychiatric Services
- Vol. 47 (10) , 1118-1120
- https://doi.org/10.1176/ps.47.10.1118
Abstract
Risperidone, an atypical antipsychotic, was introduced into clinical use in New York State facilities in April 1994. In this chart review study, records were reviewed for the first 63 patients started on risperidone at the Bronx Psychiatric Center during 1994. Sixty percent of patients treated with risperidone had a positive outcome, indicated by clinical improvement either at discharge or in the hospital. Twenty- two percent required termination of risperidone treatment within the initial three months. Risperidone appeared to be associated with favorable outcome among chronic state hospital patients, including those not discharged within the first three months of treatment.Keywords
This publication has 5 references indexed in Scilit:
- Long-term follow-up of rehabilitated patients with chronic psychiatric illness in IrelandPsychiatric Services, 1996
- Risperidone in the treatment of schizophreniaAmerican Journal of Psychiatry, 1994
- A Canadian Multicenter Placebo-Controlled Study of Fixed Doses of Risperidone and Haloperidol in the Treatment of Chronic Schizophrenic PatientsJournal of Clinical Psychopharmacology, 1993
- Risperidone versus haloperidol in the treatment of chronic schizophrenic patients: a parallel group double-blind comparative trialYonsei Medical Journal, 1993
- Therapeutic effect and safety of increasing doses of risperidone (R 64766) in psychotic patientsPsychopharmacology, 1989